HIV integrase inhibitors, pharmaceutical compositions and methods for their use
US7138408B2 · kind B2 · utility
9Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2005 |
| Grant date | Nov 21, 2006 |
| Priority date | — |
| Expiry date | Oct 14, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Beta-carboline hydroxamic acid compounds represented by formula (I)are described. The beta-carboline hydroxamic acid compounds and compositions containing those compounds may be used to inhibit or modulate the activity of HIV integrase enzyme and to treat HIV integrase-mediated diseases and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.